TGFB1 and renal fibrosis: Studies in mouse models have shown that inhibition of TGF-β signaling with a dominant-negative mutant of TGF-β receptor II led to amelioration of pancreatic fibrosis [35], and inhibition of p38MAPK with the specific inhibitor attenuated renal fibrosis [36].